Skip to content

Effect of esophageal pressure-guided lung-diaphragm protective ventilation on ventilator-free days at 28 days in patients with ARDS

Effect of esophageal pressure-guided lung-diaphragm protective ventilation on ventilator-free days at 28 days in patients with ARDS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078820
Enrollment
Unknown
Registered
2023-12-19
Start date
2023-12-19
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Interventions

Control group:standard treatment
intervention group:place an esophageal pressure monitoring tube and set ventilator parameters based on monitoring values

Sponsors

The Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (i)Age =18 years; (ii) Received invasive mechanical ventilation for no more than 48 h and expected duration of mechanical ventilation for more than 72 h at the time of inclusion. (iii) PaO2/FiO2 =150 mmHg.

Exclusion criteria

Exclusion criteria: Time of invasive mechanical ventilation before transferring to ICU>48h; ?pregnant women; ?patients who are not suitable for the placement of esophageal pressure monitoring tube; ?refuse to be enrolled in the study; ?end-stage patients; ?patients with neuromuscular blocking disease, severe central nervous system pathology; ?patients who are under other studies; ?combined with COPD or ILD and other chronic lung diseases; ?serious coagulation dysfunction; ?pneumothorax, esophago-tracheal Fistula, esophageal tracheal fistula, tracheomediastinal fistula, etc.; ? receiving ECMO treatment; ? hematologic disease, liver and kidney transplantation, bone marrow transplantation, severe cardiac disease, hemodynamic instability, and other conditions that are not suitable for inclusion in the study in the opinion of the clinician-investigator.

Design outcomes

Primary

MeasureTime frame
ventilator-free days at 28 days;

Secondary

MeasureTime frame
Diaphragm thickening fraction;LOS in ICU;ICU morbidity and mortality;

Countries

CHINA

Contacts

Public ContactShen Feng

The Affiliated Hospital of Guizhou Medical University

doctorshenfeng@163.com+86 135 1199 9117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026